![](/img/cover-not-exists.png)
Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma
Mark A. Socinski, Alan B. Sandler, Valerie K. Israel, Heidi H. Gillenwater, Langdon L. Miller, Paula K. Locker, Alessandro Antonellini, Gary L. Elfring, Ronald B. NataleVolume:
95
Year:
2002
Language:
english
Pages:
8
DOI:
10.1002/cncr.10852
File:
PDF, 86 KB
english, 2002